BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22352843)

  • 1. Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.
    Fokina AA; Meschaninova MI; Durfort T; Venyaminova AG; François JC
    Biochemistry; 2012 Mar; 51(11):2181-91. PubMed ID: 22352843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective cleavage of structured RNAs by tandems of 10-23 DNAzymes with 3'-modified oligo(2'-O-methylribonucleotide)-effectors.
    Fokina A; Novopashina D; Meschaninova M; Vorobjeva M; Zenkova M; Francois JC; Venyaminova A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):525-6. PubMed ID: 18776485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two DNAzymes targeting the telomerase mRNA with large difference in Mg2+ concentration for maximal catalytic activity.
    Yuan BF; Xue Y; Luo M; Hao YH; Tan Z
    Int J Biochem Cell Biol; 2007; 39(6):1119-29. PubMed ID: 17499543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the function of nucleotides in the catalytic cores of the 8-17 and 10-23 DNAzymes by abasic nucleotide and C3 spacer substitutions.
    Wang B; Cao L; Chiuman W; Li Y; Xi Z
    Biochemistry; 2010 Sep; 49(35):7553-62. PubMed ID: 20698496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief communication: stability and catalytic activity of novel circular DNAzymes.
    Seifert G; Taube T; Paal K; von Einsiedel HG; Wellmann S; Henze G; Seeger K; Schroff M; Wittig B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):785-93. PubMed ID: 16898416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
    Lam JC; Withers JB; Li Y
    J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific cleavage of mutant ABL mRNA by DNAzyme is facilitated by peptide nucleic acid binding to RNA substrate.
    Kim JE; Yoon S; Mok H; Jung W; Kim DE
    FEBS Lett; 2012 Nov; 586(21):3865-9. PubMed ID: 23010596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).
    Wu Y; Yu L; McMahon R; Rossi JJ; Forman SJ; Snyder DS
    Hum Gene Ther; 1999 Nov; 10(17):2847-57. PubMed ID: 10584930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA cleaving '10-23' DNAzymes with enhanced stability and activity.
    Schubert S; Gül DC; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    Nucleic Acids Res; 2003 Oct; 31(20):5982-92. PubMed ID: 14530446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaining target access for deoxyribozymes.
    Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A post-labeling approach for the characterization and quantification of RNA modifications based on site-directed cleavage by DNAzymes.
    Meusburger M; Hengesbach M; Helm M
    Methods Mol Biol; 2011; 718():259-70. PubMed ID: 21370054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion analysis in the catalytic region of the 10-23 DNA enzyme.
    Zaborowska Z; Schubert S; Kurreck J; Erdmann VA
    FEBS Lett; 2005 Jan; 579(2):554-8. PubMed ID: 15642375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human papillomavirus expression using DNAzymes.
    Benítez-Hess ML; Reyes-Gutiérrez P; Alvarez-Salas LM
    Methods Mol Biol; 2011; 764():317-35. PubMed ID: 21748650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-site selection for the 10-23 DNAzyme.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid sequence analysis using DNAzymes.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():291-302. PubMed ID: 15017058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
    Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
    Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.
    Ali MM; Aguirre SD; Mok WW; Li Y
    Methods Mol Biol; 2012; 848():395-418. PubMed ID: 22315083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-17 DNAzyme modified with purine analogs in its catalytic core: the conservation of the five-membered moieties of purine residues.
    Rong W; Xu L; Liu Y; Yu J; Zhou Y; Liu K; He J
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4238-41. PubMed ID: 22672797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An allosteric DNAzyme with dual RNA-cleaving and DNA-cleaving activities.
    Jiang D; Xu J; Sheng Y; Sun Y; Zhang J
    FEBS J; 2010 Jun; 277(11):2543-9. PubMed ID: 20553490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
    Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.